AdvisorShares Restates NAV for MSOS Daily Leveraged ETF After Accounting Error
On March 6, 2026, AdvisorShares revealed a significant update regarding its AdvisorShares MSOS Daily Leveraged ETF (NYSE Arca: MSOX), a fund primarily focused on the cannabis industry. The company announced that the previously reported net asset value (NAV) per share has been restated. This restatement was necessary due to a miscalculation in income accruals linked to total return swaps held by the fund from December 22, 2025, to February 2, 2026.
The discrepancies were identified by AdvisorShares after being informed of the error. In response, the fund took quick action, instructing the Fund Administrator to carry out an investigation to determine the extent of the issue and to rectify it. As a result, the NAV figures for various dates were recalibrated, reflecting a new adjusted value per share. For example, on December 22, 2025, the initially reported NAV was 4.18133 but has now been corrected to 4.15513.
Among the other adjustments, several dates reflected similar corrections, highlighting the erroneous nature of the accrued income calculations. This process has prompted AdvisorShares to revise its oversight and implement stricter controls and procedures on income accrual accounting related to total return swaps.
Shareholders of MSOX were encouraged to ask for further details by contacting AdvisorShares Investor Relations directly. The leveraged ETF aims to provide sophisticated traders with exposure to the cannabis market, functioning on a daily leverage objective that approximates two times the exposure of the underlying US Cannabis ETF (MSOS).
In light of this situation, AdvisorShares emphasized the importance of understanding the inherent risks of such investment vehicles, particularly for individuals seeking daily trading opportunities. Investors are reminded to assess the ETF's prospectus to gain insight into associated risks and expenses.
AdvisorShares, established as a prominent player in the actively managed ETF arena, provides a variety of fund options, focusing specifically on cannabis-related investments. Through dedicated efforts to maintain transparency and investor protection, the company strives to deliver innovative financial solutions.
Moving forward, the company remains committed to closely monitoring the performance of its fund administrator in light of these recent changes and will keep stakeholders informed for any future developments regarding the NAV restatement. In summary, potential investors should approach their decision-making process cautiously, particularly in leveraging investments within this dynamic and rapidly evolving market sector.
With the volatile nature of leveraged ETFs, the company urges investors to recognize the importance of active portfolio management and to remain aware of market shifts that can extensively impact their investments. This recent NAV restatement underscores the necessity of diligence in both fund management and personal investment strategies within the financial marketplace.
The discrepancies were identified by AdvisorShares after being informed of the error. In response, the fund took quick action, instructing the Fund Administrator to carry out an investigation to determine the extent of the issue and to rectify it. As a result, the NAV figures for various dates were recalibrated, reflecting a new adjusted value per share. For example, on December 22, 2025, the initially reported NAV was 4.18133 but has now been corrected to 4.15513.
Among the other adjustments, several dates reflected similar corrections, highlighting the erroneous nature of the accrued income calculations. This process has prompted AdvisorShares to revise its oversight and implement stricter controls and procedures on income accrual accounting related to total return swaps.
Shareholders of MSOX were encouraged to ask for further details by contacting AdvisorShares Investor Relations directly. The leveraged ETF aims to provide sophisticated traders with exposure to the cannabis market, functioning on a daily leverage objective that approximates two times the exposure of the underlying US Cannabis ETF (MSOS).
In light of this situation, AdvisorShares emphasized the importance of understanding the inherent risks of such investment vehicles, particularly for individuals seeking daily trading opportunities. Investors are reminded to assess the ETF's prospectus to gain insight into associated risks and expenses.
AdvisorShares, established as a prominent player in the actively managed ETF arena, provides a variety of fund options, focusing specifically on cannabis-related investments. Through dedicated efforts to maintain transparency and investor protection, the company strives to deliver innovative financial solutions.
Moving forward, the company remains committed to closely monitoring the performance of its fund administrator in light of these recent changes and will keep stakeholders informed for any future developments regarding the NAV restatement. In summary, potential investors should approach their decision-making process cautiously, particularly in leveraging investments within this dynamic and rapidly evolving market sector.
With the volatile nature of leveraged ETFs, the company urges investors to recognize the importance of active portfolio management and to remain aware of market shifts that can extensively impact their investments. This recent NAV restatement underscores the necessity of diligence in both fund management and personal investment strategies within the financial marketplace.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.